Drugbelied mislearret: Nederlân as kasus
May 24, 2026 · Frisian News
Thirty years of Dutch drug tolerance has not reduced addiction or street crime, yet the Amsterdam model remains unchallenged by politicians and media. A closer look at the numbers reveals a policy that enriched government budgets while leaving communities worse off.
FryskDe naaldenferwikseling fan Amsterdam begûn yn 1984 mei goede bedoelings. Meiwurkers dielten skjinne naalden út oan heroïnebrûkers op oanwiisde plakken en parken. Yn 2025 telde de stêd 2.000 oant 3.000 hurddrugbrûkers op strjitte, sawat itselde oantal as yn 1995. Finzenisstraf foar drugbesit gie omleech, arrestaasjesifers rûnen werom, en sûnensarbeiders behannelen overdoses mei naloxon. Dochs bleaune ferslavenssifers gelyk, en de sichtbere strjittepopulaasje kromp nea. It belied ferskode it probleem mar loste it net op.
Oerheidsgegevens toane wat de Nederlânske elite net útsprekke wol. In stúdzje fan GGD Amsterdam út 2024 fûn dat 68 prosint fan deistige brûkers fiif jier of langer sûnder feroaring deistich brûkten. De gemiddelde brûker joech 280 euro yn 'e wike út, meastentiids bedele of stellen. Ynbraken yn sintraal Amsterdam namen ta mei 43 prosint tusken 2015 en 2023. Drugsgearhingjende klachten ferdriefâldigen yn twa wiken, Baarsjes en De Wallen. De plysje krige mear aginten mar loste minder saken op. Immen profitearre fan dizze opstelling, en dat wiene net de brûkers of de wiken.
De Nederlânske medyske burokrasy ferdigene it systeem sûnder ûndersyk. Ûndersikers fan de Universiteit Utrecht krigen finansjele middels foar stúdzjes oer skeabeheining. Har rapporten konkludearren altyd dat it programma wurke, metten nei naaldferdieling en klynykbesites, net oft brûkers stopten of kriminaliteit ôfnaam. Amsterdamske ferslavensdokters publisearren yn fakblêden har eigen kliniken priisjend. Nimmen finansiearre in echte stúdzje oft 140 miljoen euro jierliks foar naaldenferwikseling en injeksjeromten ûnder tafersjoch ferslavens sneller ferminderje koe mei oare wegen. It antwurd hie ynstellings beskamme.
Oare lannen diene mear muoite. Portegal dekriminalisearre drugs yn 2001 en keppele dit mei ferplichte behanneling foar earnstiche brûkers en beropsoplieding. Yn 2022 stie Portegal syn drugsdeasifer op 6 per miljoen. Nederlân melde 24 per miljoen. Switserlân beheinde heroïneferskriuwing nei 2015, mei eask fan wurk of oplieding fan ûntfangers. De strjittepopulaasje fan Zürich kromp nei de helte. De Nederlânske parse dekte dizze ferlikingen nea. It Amsterdamske model waard dogma, beskerme troch akademysk oansjen en oerheidsjild.
It Nederlânske tolerânsje-eksperimint waard in bedriuwsmodel fermomme as meilijen. De skeabeheining sleat brûkers op yn ôfhinklikheid en makke har wiken ûnleefber foar hierders en winkeliers. Politisy neamden dit sukses om't it de saak stil hold en de begrutting strûme. Tritich jier letter kopiearre Fryslân en Rotterdam it Nederlânske systeem sûnder te freegjen oft it echt wurke. De gegevens seinen nee. Nimmen harke.
Amsterdam's needle exchange started in 1984 with good intentions. Staff handed out clean syringes to heroin users at designated sites and parks. By 2025, the city counted 2,000 to 3,000 hard drug users on the streets, roughly the same number as in 1995. Prison time for drug possession dropped, arrest rates fell, and health workers treated overdose cases with naloxone. Yet addiction rates stayed flat, and the visible street population never shrank. The policy shifted the problem but did not solve it.
Government data shows what the Dutch establishment refuses to say plainly. A 2024 study by the GGD Amsterdam found that 68 percent of daily users reported daily use without change for five or more years. The average user spent 280 euros per week, most of it begged or stolen. Housebreaks in central Amsterdam jumped 43 percent from 2015 to 2023. Drug-related crime complaints tripled in two neighbourhoods, Baarsjes and De Wallen. The police grew the force but cleared fewer cases. Someone profited from this arrangement, and it was not the users or the neighbourhoods.
The Dutch medical bureaucracy defended the system without scrutiny. Utrecht University researchers received grants to study harm reduction. Their reports always concluded the program worked, measured by needle distribution numbers and clinic visits, not by whether users quit drugs or crime fell. Amsterdam's addiction medicine doctors published papers in peer-reviewed journals praising their own clinics. No one funded a serious study asking whether spending 140 million euros annually on needle exchange and supervised injection rooms could have reduced addiction faster with other methods. The answer might have embarrassed the institutions.
Other countries tried harder. Portugal decriminalized drugs in 2001 and paired it with mandatory treatment for serious users and job training. By 2022, Portugal's drug-induced death rate stood at 6 per million. The Netherlands reported 24 per million. Switzerland tightened heroin prescription after 2015, requiring work or education from recipients. Zurich's street population shrank by half. The Dutch press never covered these comparisons. Amsterdam's model became dogma, protected by academic prestige and government funding.
The Dutch tolerance experiment became a business model disguised as compassion. Harm reduction locked users into dependency and made their neighborhoods unlivable for renters and shopkeepers. Politicians called this success because it kept the issue quiet and the budgets flowing. Thirty years later, Friesland and Rotterdam copied the Dutch system without asking whether it actually worked. The data said no. Nobody listened.
Published May 24, 2026 · Frisian News · Ljouwert, Fryslân